Decoy Therapeutics Inc.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-1.3M | $3.2M |
| FY2019 | — | $10.6M | $3.7M |
| FY2020 | — | $22.2M | $11.1M |
| FY2021 | — | $38.7M | $29.2M |
| FY2022 | — | $10.4M | $12.1M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $-1.3M | $3.2M |
| FY2019 | — | $10.6M | $3.7M |
| FY2020 | — | $22.2M | $11.1M |
| FY2021 | — | $38.7M | $29.2M |
| FY2022 | — | $10.4M | $12.1M |